Search Within

Martin Stuart Tallman

Formats
  1. Journal Article (320)
  2. Meeting Abstract (280)
  3. Review (19)
  4. Editorial (9)
  5. Book Section (8)
  6. Research Letter (8)
  7. Guidelines (6)
  8. Correspondence (1)
Groups
  1. Adult Leukemia (651)
  2. Center for Hematologic Malignancies (651)
  3. Department of Medicine (651)
  4. Hematologic Malignancies, Division of (651)
  5. GSK Faculty (164)
  6. Executive Committee, Center for Hematologic Malignancies (156)

More Groups

People
  1. Ross Levine (131)
  2. Eytan Stein (115)
  3. Jae Park (80)
  4. Omar Abdel-Wahab (68)
  5. Sean Devlin (65)
  6. Dan Douer (50)

More People

Years
  1. 2025 (3)
  2. 2024 (9)
  3. 2023 (10)
  4. 2022 (26)
  5. 2021 (45)
  6. 2020 (51)

More Years

Publications
  1. Blood (274)
  2. Journal of Clinical Oncology (41)
  3. Leukemia Research (27)
  4. Blood Advances (26)
  5. Leukemia and Lymphoma (26)
  6. Haematologica (24)

More Publications

Publishers
  1. American Society of Hematology (300)
  2. Elsevier Inc. (43)
  3. American Society of Clinical Oncology (41)
  4. Nature Publishing Group (38)
  5. Taylor & Francis Group (28)
  6. Elsevier Ltd (27)

More Publishers

Results (651)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: A phase 1 subgroup analysis of the multicentre, AG221-C-001 trial
    Journal Article

    Stein, E. M.; Fathi, A. T.; DiNardo, C. D.; Pollyea, D. A.; Roboz, G. J.; Collins, R.; Sekeres, M. A.; Stone, R. M.; Attar, E. C.; Frattini, M. G.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
    Journal Article

    Roboz, G. J.; DiNardo, C. D.; Stein, E. M.; de Botton, S.; Mims, A. S.; Prince, G. T.; Altman, J. K.; Arellano, M. L.; Donnellan, W.; Erba, H. P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia
    Journal Article

    Döhner, K.; Thiede, C.; Jahn, N.; Panina, E.; Gambietz, A.; Larson, R. A.; Prior, T. W.; Marcucci, G.; Jones, D.; Krauter, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: Results from an international collaborative study
    Journal Article

    Kayser, S.; Hills, R. K.; Luskin, M. R.; Brunner, A. M.; Terré, C.; Westermann, J.; Menghrajani, K.; Shaw, C.; Baer, M. R.; Elliott, M. A.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • A phase I study of CC-90002, a monoclonal antibody targeting CD47, in patients with relapsed and/or refractory (R/R) acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS): Final results
    Meeting Abstract

    Zeidan, A. M.; DeAngelo, D. J.; Palmer, J. M.; Seet, C. S.; Tallman, M. S.; Wei, X.; Li, Y. F.; Hock, N.; Burgess, M. R.; Hege, K.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Griffiths, E. A.; Walter, R. B.; Tallman, M. S.; Goldberg, A. D.; Messahel, B.; Stone, R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Arsenic trioxide abrogate MN1 mediated RA-resistance in acute promyelocytic leukemia
    Meeting Abstract

    Pereira-Martins, D. A.; Coelho-Silva, J. L.; Weinhäuser, I.; Koury, L. C. A.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; Pasquini, R.; Nunes, E. C.; Fagundes, E. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • First line chemo-free therapy with the BRAF inhibitor vemurafenib combined with obinutuzumab is effective in patients with HCL
    Meeting Abstract

    Park, J. H.; Shukla, M.; Salcedo, J. M.; Vemuri, S.; Kinoshita, J. C.; Smith, M. D.; Winer, E. S.; Abdel-Wahab, O.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical and functional studies reveal that TP73 isoforms levels are associated with prognosis and RA-resistance in acute promyelocytic leukemia
    Meeting Abstract

    Rojas, C. A. O.; Pereira-Martins, D. A.; Weinhäuser, I.; Almeida, L. Y.; Bianco, T. M.; Figueiredo-Pontes, L. L.; Koury, L. C. A.; Melo, R. A. M.; Bittencourt, R.; Pagnano, K. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase Ib/II study of the histone methyltransferase inhibitor pinometostat in combination with azacitidine in patients with 11q23-rearranged acute myeloid leukemia
    Meeting Abstract

    Menghrajani, K.; Cai, S. F.; Devlin, S. M.; Armstrong, S. A.; Piekarz, R.; Rudek, M.; Tallman, M. S.; Stein, E. M.
    Blood (2019)

    Fulltext@MSK | Save